Me still merchandises its ancestry, health analysis, and the Total Health annual package on a scale from $99 to $999 annually. Lemonaid entered the hot GLP-1 prescribing and support business in 2024, ...

Tempus AI stock had its best day on record on Tuesday after the medical tech company launched an AI-powered health concierge ...

Tempus AI says the app, olivia, is designed to centralize patients’ health data and make it accessible through artificial ...

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.

TD Cowen analyst Andrew Kligerman maintained a Hold rating on Lemonade (LMND – Research Report) today and set a price target of $17.00. The ...